{"id":10857,"date":"2025-09-23T08:34:34","date_gmt":"2025-09-23T07:34:34","guid":{"rendered":"https:\/\/blog.caixaresearch.org\/?p=10857"},"modified":"2025-09-23T08:56:55","modified_gmt":"2025-09-23T07:56:55","slug":"31-biomedical-innovations-that-will-drive-the-future-of-health-2025","status":"publish","type":"post","link":"https:\/\/blog.caixaresearch.org\/en\/31-biomedical-innovations-that-will-drive-the-future-of-health-2025\/","title":{"rendered":"31 biomedical innovations that will drive the future of health"},"content":{"rendered":"

\"\"<\/p>\n

The \u201dla Caixa\u201d Foundation has announced the results of the 2025 call for proposals for its <\/b>CaixaImpulse<\/b><\/a> programme, through which it supports 31 biomedical projects from research centres, hospitals and universities in Spain and Portugal. In total, the organisation will allocate 3.8 million euros to this initiative, which aims to speed up the arrival of these innovations on the market so they can reach the patients who may need them. CaixaImpulse also promotes the creation of new products, services and companies linked to the life sciences and health.<\/b><\/p>\n

The winning projects \u2013 chosen from among 428 applications received \u2013 were assessed by six panels of international experts and professionals in the field. Among those selected this year are several that could transform cancer treatment: from non-invasive blood tests for advanced lung cancer to cell-based immunotherapies for aggressive childhood tumours. A new digital solution has also been developed for the treatment of complex wounds, which will enhance support for healthcare professionals. In women\u2019s health, an innovative mesh has been developed for pelvic organ prolapse, in the field of genetic diseases, progress is being made toward safer RNA-based therapies, and in neurodegenerative diseases, advances are being made in the early detection of amyotrophic lateral sclerosis.<\/span><\/p>\n

By area of activity, 14 of the selected projects fall within the field of therapies. These are followed by projects related to medical devices, 12 of which stand out for their potential to improve healthcare. In the field of diagnostics, four proposals have been identified with the capacity to transform the early detection of diseases and, finally, one project is focused on digital health.<\/span><\/p>\n

In terms of funding, the awardees receive between 50,000 and 500,000 euros to develop their projects over the following years, depending on their stage of maturity. In this call, 17 projects entered phase 1 (up to 50,000 euros), 11 entered phase 2 (up to 150,000 euros) and 3 reached phase 3 (up to 500,000 euros). The programme allows projects, once they achieve specific development milestones and following assessment by the evaluation committee, to progress to later phases with greater funding.<\/span><\/p>\n

Training and expert support for the projects<\/b><\/p>\n

CaixaImpulse supports biomedical projects in the field of innovation and knowledge transfer, helping researchers to validate their assets and define their exploitation and valorisation strategy in order to bring research results closer to the market. In addition to financial support, they also have access to mentoring, consultancy and guidance from international experts across various areas of the innovation ecosystem.<\/span><\/p>\n

In addition, the researchers leading projects in phase 2 will receive four weeks of specialised training on technology transfer, intellectual property law, pitching to investors and closing commercial agreements.<\/span><\/p>\n

In the words of Paola Isetta, deputy director of Fellowships, Research and Innovation at the \u201dla Caixa\u201d Foundation, \u201cThe outcome of the 2025 CaixaImpulse call reaffirms the Foundation\u2019s commitment to innovation in biomedicine and health. Through an investment of 3.8 million euros, the development of 31 projects in Spain and Portugal is being promoted with the aim of speeding up their arrival on the market to improve patients\u2019 quality of life. In addition to financial support, researchers receive mentoring and expert guidance to bring their innovations to market with greater strength.\u201d<\/span><\/p>\n

The call is carried out in collaboration with <\/span>Criteria Bio Ventures<\/span><\/a>, CriteriaCaixa\u2019s venture capital fund specialising in biotechnology and the life sciences. In Portugal, the call is run in partnership with the Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT) of the Portuguese Ministry of Science, Technology and Higher Education, which in this edition is funding two of the Portuguese projects selected in phase 1.<\/span><\/p>\n

The \u201dla Caixa\u201d Foundation launched this programme to support innovation and knowledge transfer in biomedicine and health in 2015. Since then, the organisation has allocated 28.8 million euros to support 263 projects, which have led to the creation of 54 spin-offs, which have in turn secured additional co-financing through other competitive calls or private investors amounting to more than 180 million euros. These are some of the <\/span>achievements of the first decade of CaixaImpulse<\/span><\/a>, the \u201dla Caixa\u201d Foundation\u2019s call for proposals to support health innovation projects, run in collaboration with Criteria Bio Ventures.<\/span><\/p>\n

 <\/p>\n

We invite you to discover the selected projects below, arranged from the earliest to the most advanced stages:<\/strong><\/p>\n

Working towards a better treatment for autism<\/strong><\/em><\/a><\/p>\n